Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Novel Treatment Opportunities for Sulfur Mustard-Related Cancers: Genetic and Epigenetic Perspectives Publisher Pubmed



Rahmani S1 ; Abdollahi M1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Archives of Toxicology Published:2017


Abstract

Sulfur mustard (SM), also known as mustard gas, is a chemical weapon which by now has been used in many wars. The most concerning SM toxic effect is probable carcinogenicity. In this study, the genetic and epigenetic mechanisms of SM carcinogenicity, by focusing on treatment of SM-associated malignancies, particularly gene therapeutics, cancer vaccines, and epigenetic medications, have been criticized. The required data were collected through an organized search on valid scientific databases. For SM carcinogenicity due to acute or chronic exposure, the entire original and review articles were evaluated. In addition, studies on the therapeutic effects of available genetic and epigenetic medications were included. Currently, four gene therapeutics, two cancer vaccines with genetic bases, and seven epigenetic medications are available for cancer treatment. Genetic and epigenetic cancer treatments including Gendicine, Imlygic, Provenge, Cimavax-EGF, Azacitidine, Vorinostat, Romidepsin, and Belinostat will yield outstanding benefits for SM-exposed patients who suffer from cancer. © 2017, Springer-Verlag GmbH Germany.
Other Related Docs
12. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
13. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
16. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
17. Pharmacoepigenetics of Immunological Disorders, Pharmacoepigenetics (2019)
18. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
20. Peptide and Protein Vaccines for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
25. Mycosis Fungoides Two Decades After Exposure to Sulphur Mustard: A Follow-Up of 1100 Victims, Journal of the European Academy of Dermatology and Venereology (2017)
27. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
30. Peptide and Protein Vaccines for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
31. The Role of Dna Methylation in Cancer, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
32. Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care, Cancer Genetics and Psychotherapy (2017)
34. Oncolytic Virotherapy: Challenges and Solutions, Current Problems in Cancer (2021)
37. Tumor Immunology, Clinical Immunology (2022)
38. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
41. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)